Ajanta Pharma Limited (AJANTPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.066x

Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.84 Billion ≈ $30.71 Million USD) by net assets (Rs43.15 Billion ≈ $466.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Ajanta Pharma Limited to measure how much of total assets are equity-financed.

Ajanta Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Ajanta Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ajanta Pharma Limited (AJANTPHARM) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Ajanta Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ajanta Pharma Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Guoyuan Securities Co Ltd
SHE:000728
0.038x
Sichuan Changhong Electric Co Ltd
SHG:600839
0.070x
Dyno Nobel Ltd
AU:DNL
0.036x
Resideo Technologies Inc
NYSE:REZI
-0.050x
Faw Car Co Ltd
SHE:000800
-0.031x
Hyundai Motor Co Pref
KO:005387
-0.039x
Icahn Enterprises LP
NASDAQ:IEP
0.004x
RTL GROUP UNSP.ADR 10
F:RRTU
N/A

Annual Cash Flow Conversion Efficiency for Ajanta Pharma Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Ajanta Pharma Limited worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs37.90 Billion
≈ $409.91 Million
Rs11.57 Billion
≈ $125.15 Million
0.305x +38.73%
2024-03-31 Rs35.67 Billion
≈ $385.80 Million
Rs7.85 Billion
≈ $84.90 Million
0.220x -5.83%
2023-03-31 Rs33.88 Billion
≈ $366.40 Million
Rs7.92 Billion
≈ $85.63 Million
0.234x +35.73%
2022-03-31 Rs32.64 Billion
≈ $353.03 Million
Rs5.62 Billion
≈ $60.78 Million
0.172x -10.50%
2021-03-31 Rs29.96 Billion
≈ $323.97 Million
Rs5.76 Billion
≈ $62.33 Million
0.192x +9.46%
2020-03-31 Rs25.99 Billion
≈ $281.06 Million
Rs4.57 Billion
≈ $49.40 Million
0.176x +5.29%
2019-03-31 Rs22.45 Billion
≈ $242.81 Million
Rs3.75 Billion
≈ $40.53 Million
0.167x +19.39%
2018-03-31 Rs20.41 Billion
≈ $220.77 Million
Rs2.85 Billion
≈ $30.87 Million
0.140x -63.95%
2017-03-31 Rs15.68 Billion
≈ $169.54 Million
Rs6.08 Billion
≈ $65.76 Million
0.388x +39.29%
2016-03-31 Rs11.72 Billion
≈ $126.75 Million
Rs3.26 Billion
≈ $35.30 Million
0.278x -16.18%
2015-03-31 Rs8.41 Billion
≈ $90.96 Million
Rs2.79 Billion
≈ $30.22 Million
0.332x -7.21%
2014-03-31 Rs5.93 Billion
≈ $64.16 Million
Rs2.12 Billion
≈ $22.97 Million
0.358x -40.32%
2013-03-31 Rs3.93 Billion
≈ $42.51 Million
Rs2.36 Billion
≈ $25.50 Million
0.600x +133.59%
2012-03-31 Rs2.98 Billion
≈ $32.23 Million
Rs765.41 Million
≈ $8.28 Million
0.257x -41.57%
2011-03-31 Rs2.29 Billion
≈ $24.75 Million
Rs1.01 Billion
≈ $10.88 Million
0.440x -14.54%
2010-03-31 Rs1.85 Billion
≈ $20.00 Million
Rs951.16 Million
≈ $10.29 Million
0.514x +133.60%
2009-03-31 Rs1.57 Billion
≈ $16.99 Million
Rs345.92 Million
≈ $3.74 Million
0.220x +55.96%
2008-03-31 Rs1.35 Billion
≈ $14.62 Million
Rs190.81 Million
≈ $2.06 Million
0.141x -22.80%
2007-03-31 Rs1.16 Billion
≈ $12.50 Million
Rs211.30 Million
≈ $2.29 Million
0.183x -21.67%
2006-03-31 Rs1.09 Billion
≈ $11.74 Million
Rs253.45 Million
≈ $2.74 Million
0.233x +446.42%
2005-03-31 Rs978.24 Million
≈ $10.58 Million
Rs-65.93 Million
≈ $-713.01K
-0.067x --

About Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$4.68 Billion
Rs432.93 Billion INR
Market Cap Rank
#3693 Global
#165 in India
Share Price
Rs3465.20
Change (1 day)
+0.84%
52-Week Range
Rs2388.40 - Rs3575.30
All Time High
Rs3575.30
About

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic a… Read more